These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 38066496)

  • 41. Perceptions of barriers to cervical cancer screening among Saudi women: A cross-sectional study.
    Elgzar WT; Alshahrani MA; Al-Thubaity DD; Nahari MH; Ibrahim HA; Sayed SH; El Sayed HA
    Afr J Reprod Health; 2022 Jul; 26(7s):33-42. PubMed ID: 37585008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia.
    Fentie AM; Tadesse TB; Gebretekle GB
    BMC Womens Health; 2020 Jul; 20(1):147. PubMed ID: 32677933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
    Magaji FA; Mashor MI; Anzaku SA; Hinjari AR; Cosmas NT; Kwaghe BV; Ali JM; Christian EN; Sagay AS; Chandler A; Khan I; Murphy RL; Hou L; Musa J
    BMC Public Health; 2024 Jan; 24(1):193. PubMed ID: 38229083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knowledge and practice of cervical cancer screening and its associated factors among women attending maternal health services at public health institutions in Assosa Zone, Benishangul-Gumuz, Northwest Ethiopia, 2022: a cross-sectional study.
    Gelassa FR; Nagari SL; Jebena DE; Belgafo D; Teso D; Teshome D
    BMJ Open; 2023 May; 13(5):e068860. PubMed ID: 37188474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Baseline knowledge on risk factors, symptoms and intended behavior of women and men towards screening and treatment of cervical cancer in rural Uganda: a cross-sectional study.
    Nakisige C; de Fouw M; Nakalembe M; Orem J; Atukonyera D; Musheshe M; Koot J; de Zeeuw J; Beltman J; Stekelenburg J
    BMC Cancer; 2024 Apr; 24(1):450. PubMed ID: 38605317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Applying the Health Belief Model to cervical cancer screening uptake among women in Ethiopia: a systematic review and meta-analysis.
    Yirsaw AN; Tefera M; Bogale EK; Anagaw TF; Tiruneh MG; Fenta ET; Endeshaw D; Adal O; Tareke AA; Jemberu L; Getachew E; Belayneh AG; Andarge GA; Seid K; Lakew G
    BMC Cancer; 2024 Oct; 24(1):1294. PubMed ID: 39427116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early age at menarche and history of sexually transmitted infections significantly predict cervical cancer screening uptake among women aged 25-49 years: evidence from the 2021 Côte d'Ivoire demographic and health survey.
    Okyere J; Ayebeng C; Dickson KS
    BMC Health Serv Res; 2024 Apr; 24(1):423. PubMed ID: 38570834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determinants of cervical cancer screening utilization among HIV-positive women, in public general hospitals of Central Zone, Tigray, Ethiopia, 2020: Case-control study.
    Gebremeskel TG; Gebretatios MZ
    PLoS One; 2023; 18(12):e0289042. PubMed ID: 38085714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlates of cervical cancer prevention advocacy and cervical cancer screening in Uganda: Cross-sectional evaluation of a conceptual model.
    Wagner GJ; Matovu JKB; Juncker M; Namisango E; Bouskill K; Nakami S; Beyeza-Kashesya J; Luyirika E; Wanyenze RK
    Medicine (Baltimore); 2023 Aug; 102(34):e34888. PubMed ID: 37653775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving intervention design to promote cervical cancer screening among hard-to-reach women: assessing beliefs and predicting individual attendance probabilities in Bogotá, Colombia.
    Barrera Ferro D; Bayer S; Brailsford S; Smith H
    BMC Womens Health; 2022 Jun; 22(1):212. PubMed ID: 35672816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys.
    Okyere J; Duodu PA; Aduse-Poku L; Agbadi P; Nutor JJ
    BMC Public Health; 2021 Jun; 21(1):1071. PubMed ID: 34090372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knowledge, attitude and practice towards cervical cancer prevention among mothers of girls aged between 9 and 14 years: a cross sectional survey in Zimbabwe.
    Zibako P; Tsikai N; Manyame S; Ginindza TG
    BMC Womens Health; 2021 Dec; 21(1):426. PubMed ID: 34930221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Knowledge, Attitude, and Practice Toward Cervical Cancer Screening Among Women Attending Health Facilities in Central Ethiopia.
    Gebisa T; Bala ET; Deriba BS
    Cancer Control; 2022; 29():10732748221076680. PubMed ID: 35315704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beliefs and perceptions regarding cervical cancer and screening associated with Pap smear uptake in Johannesburg: A cross-sectional study.
    Chisale Mabotja M; Levin J; Kawonga M
    PLoS One; 2021; 16(2):e0246574. PubMed ID: 33566798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda.
    Wanyenze RK; Bwanika JB; Beyeza-Kashesya J; Mugerwa S; Arinaitwe J; Matovu JKB; Gwokyalya V; Kasozi D; Bukenya J; Makumbi F
    Glob Health Action; 2017; 10(1):1380361. PubMed ID: 29035163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Education attainment as a predictor of HIV risk in rural Uganda: results from a population-based study.
    Smith J; Nalagoda F; Wawer MJ; Serwadda D; Sewankambo N; Konde-Lule J; Lutalo T; Li C; Gray RH
    Int J STD AIDS; 1999 Jul; 10(7):452-9. PubMed ID: 10454180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Health care seeking behaviour towards cervical cancer screening among women aged 30-49 years in Arbaminch town, Southern Ethiopia, 2023.
    Kussia B; Shewangizaw M; Abebe S; Alemu H; Simon T
    BMC Cancer; 2024 Jan; 24(1):38. PubMed ID: 38183018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
    Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
    BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usage of cervical cancer screening services among HIV-positive women in Southern Ethiopia: a multicentre cross-sectional study.
    Mesfin AH; Gufue ZH; Alemayehu MA; Kedida BD; Legese B; Gejo NG
    BMJ Open; 2023 Jul; 13(7):e068253. PubMed ID: 37500275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors associated with age at first screening for cervical cancer among adult Cape Verdean women: a cross-sectional study.
    Okyere J; Ayebeng C; Dickson KS
    BMC Public Health; 2024 Sep; 24(1):2444. PubMed ID: 39251925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.